| CEUEX | TPYRX | CEUEX / TPYRX | |
| Total Expense Ratio | 1.09 | 0.79 | 138% |
| Annual Report Gross Expense Ratio | 1.09 | 1.01 | 108% |
| Fund Existence | 24 years | 3 years | - |
| Gain YTD | 3.541 | -1.852 | -191% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 50000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 141B | 91.8M | 153,595% |
| Annual Yield % from dividends | 2.46 | 1.50 | 164% |
| Returns for 1 year | 7.49 | -4.93 | -152% |
| Returns for 3 years | 16.72 | N/A | - |
| Returns for 5 years | -4.16 | N/A | - |
| Returns for 10 years | 49.35 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 17.54 | 0.25 | +1.45% |
| ICON Health and Information Tech Inv | |||
| KLCKX | 11.61 | 0.14 | +1.22% |
| Federated Hermes Kaufmann Large Cap R | |||
| MAIMX | 27.82 | -0.02 | -0.07% |
| Victory Integrity Mid-Cap Value A | |||
| PRDGX | 89.92 | -0.39 | -0.43% |
| T. Rowe Price Dividend Growth | |||
| MSEGX | 55.92 | -1.21 | -2.12% |
| Morgan Stanley Inst Growth A | |||